Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
October 16, 2004
Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model
Andreas Evers, Gerhard Klebe
Journal of Medicinal Chemistry
|
February 18, 2005
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor
Andreas Evers, Thomas Klabunde
Angewandte Chemie (International Ed. in English)
|
December 26, 2003
Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening
Andreas Evers, Gerhard Klebe
Chembiochem : a European Journal of Chemical Biology
|
March 26, 2005
GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects
Thomas Klabunde, Andreas Evers
Chemmedchem
|
November 13, 2009
Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors
Dennis M Krüger, Andreas Evers
Journal of Molecular Biology
|
November 11, 2003
Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials
Andreas Evers, Holger Gohlke, Gerhard Klebe
Journal of Chemical Information and Modeling
|
July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similarities
Thomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry
|
April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening
Thomas Klabunde, Clemens Giegerich, Andreas Evers
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2013
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Martin Lorenz, Andreas Evers, Michael Wagner
Pharmaceutics
|
February 26, 2022
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling
Andreas Evers, Didier Clénet, Stefania Pfeiffer-Marek
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
October 16, 2004
Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model
Andreas Evers, Gerhard Klebe
Journal of Medicinal Chemistry
|
February 18, 2005
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor
Andreas Evers, Thomas Klabunde
Angewandte Chemie (International Ed. in English)
|
December 26, 2003
Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening
Andreas Evers, Gerhard Klebe
Chembiochem : a European Journal of Chemical Biology
|
March 26, 2005
GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects
Thomas Klabunde, Andreas Evers
Chemmedchem
|
November 13, 2009
Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors
Dennis M Krüger, Andreas Evers
Journal of Molecular Biology
|
November 11, 2003
Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials
Andreas Evers, Holger Gohlke, Gerhard Klebe
Journal of Chemical Information and Modeling
|
July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similarities
Thomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry
|
April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening
Thomas Klabunde, Clemens Giegerich, Andreas Evers
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2013
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Martin Lorenz, Andreas Evers, Michael Wagner
Pharmaceutics
|
February 26, 2022
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling
Andreas Evers, Didier Clénet, Stefania Pfeiffer-Marek
Page
of 6